Stem cell therapy in autism: recent insights
Dario Siniscalco,1 Suresh Kannan,2 Neomar Semprún-Hernández,3 Adrien A Eshraghi,4 Anna Lisa Brigida,5 Nicola Antonucci6 1Department of Experimental Medicine, University of Campania, Napoli, Italy; 2Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bfa4f72ec27843129bfc3184792dbf56 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bfa4f72ec27843129bfc3184792dbf56 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bfa4f72ec27843129bfc3184792dbf562021-12-02T07:43:51ZStem cell therapy in autism: recent insights1178-6957https://doaj.org/article/bfa4f72ec27843129bfc3184792dbf562018-10-01T00:00:00Zhttps://www.dovepress.com/stem-cell-therapy-in-autism-recent-insights-peer-reviewed-article-SCCAAhttps://doaj.org/toc/1178-6957Dario Siniscalco,1 Suresh Kannan,2 Neomar Semprún-Hernández,3 Adrien A Eshraghi,4 Anna Lisa Brigida,5 Nicola Antonucci6 1Department of Experimental Medicine, University of Campania, Napoli, Italy; 2Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India; 3Research Division, Autism Immunology Unit of Maracaibo, Catedra libre de Autismo, Universidad del Zulia, Maracaibo, Venezuela; 4Department of Otolaryngology, Hearing Research and Cochlear Implant Laboratory, University of Miami Miller School of Medicine, Miami, FL, USA; 5Italian Group for Studying Autism – GISA, Brescia, Italy; 6Biomedical Centre for Autism Research and Treatment, Bari, Italy Abstract: Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed. Keywords: autism spectrum disorder, stem cell, cell therapy, immune dysfunction Siniscalco DKannan SSemprún-Hernández NEshraghi AABrigida ALAntonucci NDove Medical Pressarticleautism spectrum disorderstem cellcell therapyimmune dysfunction.CytologyQH573-671ENStem Cells and Cloning: Advances and Applications, Vol Volume 11, Pp 55-67 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
autism spectrum disorder stem cell cell therapy immune dysfunction. Cytology QH573-671 |
spellingShingle |
autism spectrum disorder stem cell cell therapy immune dysfunction. Cytology QH573-671 Siniscalco D Kannan S Semprún-Hernández N Eshraghi AA Brigida AL Antonucci N Stem cell therapy in autism: recent insights |
description |
Dario Siniscalco,1 Suresh Kannan,2 Neomar Semprún-Hernández,3 Adrien A Eshraghi,4 Anna Lisa Brigida,5 Nicola Antonucci6 1Department of Experimental Medicine, University of Campania, Napoli, Italy; 2Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India; 3Research Division, Autism Immunology Unit of Maracaibo, Catedra libre de Autismo, Universidad del Zulia, Maracaibo, Venezuela; 4Department of Otolaryngology, Hearing Research and Cochlear Implant Laboratory, University of Miami Miller School of Medicine, Miami, FL, USA; 5Italian Group for Studying Autism – GISA, Brescia, Italy; 6Biomedical Centre for Autism Research and Treatment, Bari, Italy Abstract: Autism spectrum disorders (ASDs) are characterized by core domains: persistent deficits in social communication and interaction; restricted, repetitive patterns of behavior, interests, or activities. ASDs comprise heterogeneous and complex neurodevelopmental pathologies with well-defined inflammatory conditions and immune system dysfunction. Due to neurobiologic changes underlying ASD development, cell-based therapies have been proposed and applied to ASDs. Indeed, stem cells show specific immunologic properties, which make them promising candidates in ASD treatment. This comprehensive up-to-date review focuses on ASD cellular/molecular abnormalities, potentially useful stem cell types, animal models, and current clinical trials on the use of stem cells in treating autism. Limitations are also discussed. Keywords: autism spectrum disorder, stem cell, cell therapy, immune dysfunction |
format |
article |
author |
Siniscalco D Kannan S Semprún-Hernández N Eshraghi AA Brigida AL Antonucci N |
author_facet |
Siniscalco D Kannan S Semprún-Hernández N Eshraghi AA Brigida AL Antonucci N |
author_sort |
Siniscalco D |
title |
Stem cell therapy in autism: recent insights |
title_short |
Stem cell therapy in autism: recent insights |
title_full |
Stem cell therapy in autism: recent insights |
title_fullStr |
Stem cell therapy in autism: recent insights |
title_full_unstemmed |
Stem cell therapy in autism: recent insights |
title_sort |
stem cell therapy in autism: recent insights |
publisher |
Dove Medical Press |
publishDate |
2018 |
url |
https://doaj.org/article/bfa4f72ec27843129bfc3184792dbf56 |
work_keys_str_mv |
AT siniscalcod stemcelltherapyinautismrecentinsights AT kannans stemcelltherapyinautismrecentinsights AT semprunhernandezn stemcelltherapyinautismrecentinsights AT eshraghiaa stemcelltherapyinautismrecentinsights AT brigidaal stemcelltherapyinautismrecentinsights AT antonuccin stemcelltherapyinautismrecentinsights |
_version_ |
1718399244967084032 |